Pharmaceutics - De Bank Flashcards

1
Q

What is the main driving force of protein folding?

A

Hydrophobic interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 main types of things that cause chemical changes to proteins?

A

Deamidation –> Asparagine and glutamine residues

Oxidation –> Trace amounts of chemical oxidants/transition metals can cause this for His, Met, Cys, Trp and Tyr residues

Hydrolysis –> Mainly of X-Asp-Y

Disulphide formation/exchange –> Removing terminal disulphide bond will decrease Tm by 40 degrees

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What excipients are added to therapeutic proteins?

A

Solubility enhancers

Anti-absorption and anti-aggregation agents

Buffereing agents

Preservatives/anti-oxidants

Cake formers

Osmotic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do we want a layer of hydration around proteins?

A

To prevent solutes from interacting with the protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What role can cyclodextrins play in the formulation of therapeutic proteins?

A

Suppress the aggregation of proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are polysorbates?

A

Amphiphillic emulsifyers that are used in protein formulation

They stabilise proteins via…

  • Exclusion of solutes
  • Act as a chemical chaperone to aid protein refolding
  • Binding to hydrophobic patches of proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can polysorbates cause protein aggregation/denaturation?

A

They get auto-oxidised (hydrolytic degradation) to reactive peroxides and aldehydes (increasing immunogenicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What has the greatest effect on polysorbates?

A

Light exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is lyophilization?

A

Freeze drying of drugs at low temepratures (in liquid form)

Require reconstitution to administer

Lots of time for microbial contamination (compared to standard liquid preperations)

It takes time for full dissolution to occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the main disadvantage of IV administration?

A

Dose is prefilled into an IV bag with a dilutent, but adsorption of this can cause a lower concentration to be achieved

So we must minimise interfaces, to prevent aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some of the advantages and disadvantages of SC administration?

A

Advantages –> Use of an autoinjector can occur

No compounding needed at the pharmacy

Disadvantages –> Maximum dose/volume is lower (compared to IV)

BA is less than 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In terms of using protein delievery in pMDIs, what are proteins not stable in?

A

Organic solvents (eg, HCFCs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the main advantage of intravitreal administration?

A

100% bioavaliability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Entaracept (Enbrel)?

A

A TNF(a) antagonist

A fusion protein

A dimer –> so can bind to 2 molecules of TNF(a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When does insulin form hexamers?

A

In the prescence of Zinc ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the difference between long and fast acting insulin?

A

Long Acting –> Promote the formation of a hexamer, which redues solubility and promotes protein binding

Fast Acting –> Prevents the formation of hexamers and dimers, which increases the solubility

17
Q

What are the benefits of PEGylating proteins?

A

Hydrophillicity –> Improves solubility and increases BA

Flexibility –> Reduced toxicity and increases stability

Attatchment of other drugs/targeting ligands

Decreases renal clearance –> As it can fit through pores!

18
Q

What is Spray Drying?

A

A continous proccess where powders are formed (without the need for milling/sieving)

Can be aseptically

19
Q

How do we get hydrophillic biologicals into polymeric systems?

A

W/O emulsion –> electrospinning

W/O/W –> micro/nanoparticles

20
Q

How could you increase nasal insulin administration?

A

Reverse micelle formation by sodium deoxycholate

21
Q

What are the 4 different types of microneedles that could be used for transdermal insulin delivery?

A

Poke and Patch

Coat and Poke

Poke and Release

Poke and Flow

22
Q

What are the 6 different types of controlled drug release that these graphs depict?

A
23
Q

What are the 3 different types of Long-Term Release drugs?

A

Bulk Erosion –> Its hydrolysed over time, decreasing over time

Surface Erosion –> Water erodes the outside

Diffusion –> The polymer doesn’t degrade

24
Q

What are 3 stimuli that will cause insulin release in controlled drug delievery systems (CDDS)?

A

Increase in glucose –> causing glucose oxidase levels to increase

High levels of glucose bind to Phenylborinc Acid (PBA)

Glucose competitively binds to Concanavalin A (ConA)

25
Q

How does tissue engineering occur?

A

Cell isolation

Expansion of cell numbers

Seeding on a suitable scaffold

Maturation of the tissue

Implantation in the patient

26
Q

What’s the aim of tissue regeneration?

A

Promoting the healing of the bodies cells by acitivating the bodies own repair mechanisms

Provides a scaffold for the body to work with